Evaluation of primary tumor single-cell/single-nucleus datasets revealed the muscarinic receptor CHRM3 as the most highly expressed cholinergic receptor gene across various CNS tumors, including DMG. This evidence concerns the gene CHRM3 and central nervous system neoplasm.